세계의 헬스케어 품질관리(QMS) 시장 : 제공 제품별, 기능별, 이용 사례별, 최종사용자별, 지역별 - 예측(-2030년)

The global healthcare quality management (QMS) market is projected to reach USD 2.51 billion by 2030 from USD 1.42 billion in 2025, at a high CAGR of 12.1% during the forecast period. The healthcare quality management (QMS) market is progressing steadily, driven by the growing emphasis on patient safety, clinical quality, and outcome transparency. Rising regulatory requirements and government initiatives aimed at improving care standards are pushing providers to adopt structured quality management solutions. These systems enable hospitals and healthcare organizations to track performance metrics, manage risks, ensure compliance, and streamline reporting processes.

However, despite strong adoption drivers, the sector faces persistent challenges. Chief among them are data quality and fragmentation across diverse healthcare IT systems, which hinder seamless integration and insights generation, along with the high implementation and maintenance costs of quality management platforms. Addressing these barriers will be crucial for the market to deliver on its promise of safer, more efficient, and accountable healthcare delivery.

"By use case, the business intelligence & analytics segment is the largest segment during the forecast period."

The business intelligence (BI) & analytics segment accounts for the largest share of the healthcare quality management (QMS) market and is projected to maintain its lead in the coming years. This dominance is driven by the increasing need for data-driven decision-making, predictive insights, and performance optimization in healthcare organizations. BI and analytics solutions enable providers, payers, and administrators to analyze clinical, financial, and operational data in real time, supporting proactive quality improvement and regulatory compliance. By leveraging advanced analytics, healthcare institutions can identify care gaps, monitor patient outcomes, and streamline resource allocation, ultimately improving both efficiency and patient safety. The growing adoption of value-based care models and the shift toward personalized medicine further strengthen demand for BI-driven insights. Moreover, integration with cloud platforms and interoperability across diverse health IT systems enhances scalability and collaboration. As healthcare stakeholders continue to prioritize measurable quality outcomes and cost optimization, BI & analytics will remain the cornerstone use case, reinforcing its market leadership.

"By offering, the software segment is expected to register the fastest growth in the healthcare quality management (QMS) market during the forecast period."

The software segment is expected to register the fastest growth in the healthcare quality management (QMS) market during the forecast period. This growth is driven by the rising demand for scalable, specialized, and flexible solutions that streamline quality management functions such as compliance reporting, risk assessment, incident tracking, performance monitoring, and patient safety management. Software solutions help healthcare organizations automate workflows, reduce administrative burden, and provide real-time visibility into quality metrics, enabling data-driven decision-making across departments. By centralizing and standardizing processes, these solutions minimize errors and ensure alignment with evolving regulatory requirements. The increasing adoption of cloud-based platforms, integration with EHRs, and advanced analytics capabilities are further accelerating software deployment. As healthcare providers focus on improving care quality, operational efficiency, and regulatory compliance, software offerings are poised to drive significant growth in the market over the forecast period.

"The Asia Pacific is expected to witness the highest growth rate during the forecast period."

The Asia Pacific region is expected to register the fastest growth in the healthcare quality management (QMS) market over the forecast period. This growth is supported by rising government initiatives to strengthen healthcare systems, increasing investments in digital health technologies, and greater regulatory focus on patient safety and clinical quality. Rapid expansion of healthcare infrastructure, particularly in emerging economies such as India and China, is driving demand for advanced quality management solutions. The region's growing chronic disease burden and aging population are further accelerating the need for robust platforms to track outcomes, reduce medical errors, and enhance efficiency in care delivery. Additionally, the increasing adoption of cloud-based healthcare IT solutions and growing collaborations between local providers and global technology vendors are enabling faster deployment of integrated quality management systems. Together, these factors position the Asia Pacific as the fastest-growing regional market, playing a pivotal role in shaping the future of healthcare quality management (QMS) worldwide.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace. The breakdown of primary participants is as mentioned below:

• By Company Type: Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%)
• By Designation: Directors (15%), Managers (10%), and Others (75%)
• By Region: North America (39%), Europe (31%), Asia Pacific (21%), Latin America (6%), and the Middle East & Africa (3%)

Key Players in the Healthcare Quality Management (QMS) Market

The key players operating in the healthcare quality management (QMS) market include Nuance Communications, Inc. (US), Premier Inc. (US), Optum, Inc. (US), Intelex Technologies (Canada), DNV (Norway), RLDatix (US), Riskonnect, Inc. (US), HCI (Ireland), Ideagen (UK), Medisolv, Inc. (US), Valenz Health (US), OdiTek Solutions (India), The Patient Safety Company (TPSC) (Netherlands), MorCare (Harris Health) (US), YouComply, Ltd. (ViClarity) (UK), SimplerQMS (US), NAVEX Global, Inc. (US), ProviderTrust (US), MedTrainer (US), OKKALA SOLUTIONS PRIVATE LIMITED (India), SafeQual (US), Effivity Technologies, Inc. (US), Title21 Health Solutions (US), Medblaze (INFINI) (India), eTaskPro (UAE), Qualityze (US), Karminn Consultancy Network (India), and MEG (Ireland).

Research Coverage:

The report analyzes the healthcare quality management (QMS) market and aims to estimate the market size and future growth potential of various market segments, based on offering, function, use case, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights into:

• Analysis of key drivers (rising adoption of AI, ML, and predictive analytics in healthcare; increasing focus on patient safety and clinical quality; interoperability of health data & health information exchange; and growing regulatory requirements and government initiatives), restraints (data quality and fragmentation challenges across healthcare IT systems and high implementation and maintenance costs of quality management systems), opportunities (integration with patient-generated health data (PGHD) and voice and NLP for quality documentation), and challenges (data privacy and security concerns, standardization of quality measures & data models, and limited skilled workforce & training gaps) influencing the growth of the healthcare quality management (QMS) market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare quality management (QMS) market.
• Market Development: Comprehensive information on the lucrative emerging markets, offering, function, use case, end user, and region.
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare quality management (QMS) market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare quality management (QMS) market, like Nuance Communications, Inc. (US), Premier Inc. (US), Optum, Inc. (US), RLDatix (US), and Intelex Technologies (Canada).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 LIMITATIONS
  • 1.5.1 METHODOLOGY-RELATED LIMITATIONS
  • 1.5.2 SCOPE-RELATED LIMITATIONS
• 1.6 MARKET STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • 2.1.1 SECONDARY RESEARCH
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY RESEARCH
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Breakdown of primaries
    • 2.1.2.4 Insights from primary experts
• 2.2 RESEARCH METHODOLOGY DESIGN
• 2.3 MARKET SIZE ESTIMATION
• 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.5 MARKET SHARE ESTIMATION
• 2.6 STUDY ASSUMPTIONS
• 2.7 RESEARCH LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
• 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 OPPORTUNITIES FOR PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET
• 4.2 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING & COUNTRY
• 4.3 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: REGIONAL MIX (2023-2030)
• 4.5 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DEVELOPED VS. EMERGING ECONOMIES, 2025 VS. 2030 (USD MILLION)

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising adoption of AI, ML, and predictive analytics in healthcare
    • 5.2.1.2 Increasing focus on patient safety and clinical quality
    • 5.2.1.3 Interoperability of health data & health information exchange
    • 5.2.1.4 Growing regulatory requirements and government initiatives
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Data quality and fragmentation challenges across healthcare IT systems
    • 5.2.2.2 High implementation and maintenance costs of quality management systems
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Integration with patient-generated health data (PGHD)
    • 5.2.3.2 Voice and NLP for quality documentation
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Data privacy and security concerns
    • 5.2.4.2 Standardization of quality measures & data models
    • 5.2.4.3 Limited skilled workforce & training gaps
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 INDUSTRY TRENDS
  • 5.4.1 AI-DRIVEN PREDICTIVE ANALYTICS
  • 5.4.2 INTEGRATION OF CLOUD-BASED QUALITY MANAGEMENT SOLUTIONS
  • 5.4.3 EMPHASIS ON PATIENT-CENTERED CARE
  • 5.4.4 REGULATORY COMPLIANCE AND RISK MANAGEMENT
  • 5.4.5 CROSS-INDUSTRY COLLABORATION FOR INNOVATION
• 5.5 PRICING ANALYSIS
  • 5.5.1 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY KEY PLAYER (2024)
  • 5.5.2 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY REGION (2024)
  • 5.5.3 PRICING MODELS (QUALITATIVE)
• 5.6 VALUE CHAIN ANALYSIS
  • 5.6.1 PRODUCT DESIGN & DEVELOPMENT
  • 5.6.2 SYSTEM INTEGRATION & WORKFLOW CUSTOMIZATION
  • 5.6.3 IMPLEMENTATION
  • 5.6.4 QUALITY ANALYTICS & REPORTING INSIGHTS
  • 5.6.5 POST-SALES SERVICES
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT & FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Quality measurement & reporting platforms
    • 5.9.1.2 Performance & benchmarking analytics tools
    • 5.9.1.3 Business intelligence (BI) & advanced analytics
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 Interoperability/Health information exchange (HIE)/FHIR APIs
    • 5.9.2.2 Telehealth & remote patient monitoring (RPM)
    • 5.9.2.3 Data integration/Enterprise data warehouses & master data management
  • 5.9.3 ADJACENT TECHNOLOGIES
    • 5.9.3.1 Patient engagement platforms & portals (PROs)
    • 5.9.3.2 Clinical documentation improvement (CDI) & coding/RCM systems
    • 5.9.3.3 Automation & ambient clinician support (RPA, Voice/AI Scribing)
• 5.10 PATENT ANALYSIS
• 5.11 KEY CONFERENCES & EVENTS, 2025-2026
• 5.12 CASE STUDY ANALYSIS
  • 5.12.1 CASE STUDY 1: DRIVING COST SAVINGS AND CARE QUALITY THROUGH UNIFIED DATA AND ANALYTICS
  • 5.12.2 CASE STUDY 2: BOOSTING ACCURACY AND COMPLIANCE WITH AUTOMATED QUALITY REPORTING
  • 5.12.3 CASE STUDY 3: IMPROVING CARE HOME COMPLIANCE AND OPERATIONAL EFFICIENCY THROUGH AUTOMATED QUALITY MANAGEMENT
• 5.13 REGULATORY ANALYSIS
  • 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.13.2 REGULATORY LANDSCAPE
    • 5.13.2.1 North America
    • 5.13.2.2 Europe
    • 5.13.2.3 Asia Pacific
    • 5.13.2.4 Middle East & Africa
    • 5.13.2.5 Latin America
• 5.14 PORTER'S FIVE FORCES ANALYSIS
  • 5.14.1 BARGAINING POWER OF SUPPLIERS
  • 5.14.2 BARGAINING POWER OF BUYERS
  • 5.14.3 THREAT OF NEW ENTRANTS
  • 5.14.4 THREAT OF SUBSTITUTES
  • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.15 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.15.2 BUYING CRITERIA
• 5.16 UNMET NEEDS ANALYSIS
  • 5.16.1 CURRENT UNMET NEEDS
  • 5.16.2 END-USER EXPECTATIONS
• 5.17 BUSINESS MODEL ANALYSIS
  • 5.17.1 SUBSCRIPTION-BASED (SAAS) MODEL
  • 5.17.2 LICENSING & PERPETUAL SOFTWARE MODEL
  • 5.17.3 PAY-PER-USE/TRANSACTION-BASED MODEL
  • 5.17.4 ANALYTICS & BENCHMARKING SERVICES MODEL
  • 5.17.5 QUALITY TRANSFORMATION & CONSULTING MODEL
• 5.18 IMPACT OF AI/GEN AI ON HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET
  • 5.18.1 INTRODUCTION
  • 5.18.2 MARKET POTENTIAL OF AI/GEN AI IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET
  • 5.18.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
    • 5.18.3.1 Transforming healthcare quality management (QMS) with AI-powered virtual care platforms
  • 5.18.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
    • 5.18.4.1 Patient engagement solutions
    • 5.18.4.2 Population health management
    • 5.18.4.3 Patient safety software
  • 5.18.5 USER READINESS AND IMPACT ASSESSMENT
    • 5.18.5.1 User readiness
      • 5.18.5.1.1 User A: Hospitals
      • 5.18.5.1.2 User B: Outpatient & ambulatory care centers
    • 5.18.5.2 Impact assessment
      • 5.18.5.2.1 User A: Hospitals
      • 5.18.5.2.2 User B: Outpatient & ambulatory care centers
• 5.19 IMPACT OF 2025 US TARIFFS ON HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET
  • 5.19.1 INTRODUCTION
  • 5.19.2 KEY TARIFF RATES
  • 5.19.3 PRICE IMPACT ANALYSIS
  • 5.19.4 IMPACT ON COUNTRY/REGION
    • 5.19.4.1 US
    • 5.19.4.2 Europe
    • 5.19.4.3 Asia Pacific
  • 5.19.5 IMPACT ON END-USE INDUSTRIES
    • 5.19.5.1 Healthcare providers
    • 5.19.5.2 Healthcare payers

6 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING

• 6.1 INTRODUCTION
• 6.2 SOFTWARE
  • 6.2.1 INTEGRATED SUITES
    • 6.2.1.1 Increasing need for platforms to manage quality across entire care continuum to drive demand for integrated suites
  • 6.2.2 POINT SOLUTIONS
    • 6.2.2.1 Growing need for targeted tools that address specific challenges without need for enterprise-wide deployment to drive market
• 6.3 SERVICES
  • 6.3.1 IMPLEMENTATION & TRAINING
    • 6.3.1.1 Structured deployment and workforce training associated with implementation & training services to boost market
  • 6.3.2 SUPPORT SERVICES
    • 6.3.2.1 Ongoing technical assistance ensuring reliable performance of healthcare quality management (QMS) systems to support growth
  • 6.3.3 CONSULTING SERVICES
    • 6.3.3.1 Benefits such as strategic advisory and process optimization to drive demand for consulting services
  • 6.3.4 OTHER SERVICES

7 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION

• 7.1 INTRODUCTION
• 7.2 DOCUMENT MANAGEMENT
  • 7.2.1 ADVANTAGES SUCH AS STANDARDIZED CLINICAL AND OPERATIONAL WORKFLOWS AND RELIABLE AUDIT TRAILS TO DRIVE DEMAND
• 7.3 RISK MANAGEMENT
  • 7.3.1 RISING ADOPTION OF RISK MANAGEMENT SOLUTIONS FOR IMPROVING PATIENT SAFETY AND COMPLIANCE TO DRIVE GROWTH
• 7.4 AUDIT MANAGEMENT
  • 7.4.1 GROWING ADOPTION OF AUDIT MANAGEMENT SYSTEMS TO ENHANCE OPERATIONAL EFFICIENCY TO SUPPORT MARKET
• 7.5 CAPA & NONCONFORMANCE MANAGEMENT
  • 7.5.1 GROWING NEED FOR CAPA & NONCONFORMANCE MANAGEMENT TO ENHANCE HEALTHCARE QUALITY AND COMPLIANCE TO FUEL GROWTH
• 7.6 CHANGE MANAGEMENT
  • 7.6.1 RISING ADOPTION OF CHANGE MANAGEMENT SOLUTIONS TO STRENGTHEN COMPLIANCE AND QUALITY TO BOOST MARKET
• 7.7 COMPLAINT MANAGEMENT
  • 7.7.1 GROWING USE OF COMPLAINT MANAGEMENT SYSTEMS TO STRENGTHEN PATIENT SAFETY AND REGULATORY COMPLIANCE TO PROPEL MARKET
• 7.8 TRAINING MANAGEMENT
  • 7.8.1 STRENGTHENING WORKFORCE READINESS WITH TRAINING MANAGEMENT TOOLS TO CONTRIBUTE TO MARKET GROWTH
• 7.9 OTHER FUNCTIONS

8 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE

• 8.1 INTRODUCTION
• 8.2 QUALITY REPORTING
  • 8.2.1 ADVANTAGES SUCH AS STRUCTURED COLLECTION AND ANALYSIS OF PHYSICIAN PERFORMANCE TO BOOST MARKET
• 8.3 BUSINESS INTELLIGENCE & ANALYTICS
  • 8.3.1 DEPLOYMENT OF ADVANCED ANALYTICS TO STRENGTHEN EFFICIENCY AND ACCOUNTABILITY TO DRIVE GROWTH
• 8.4 CLINICAL RISK MANAGEMENT
  • 8.4.1 ADOPTION OF CLINICAL RISK MANAGEMENT TO ENHANCE PATIENT SAFETY, CARE QUALITY, AND ORGANIZATIONAL RESILIENCE
• 8.5 PROVIDER PERFORMANCE MANAGEMENT
  • 8.5.1 OPTIMIZING CLINICIAN AND NETWORK PERFORMANCE THROUGH DATA-DRIVEN QUALITY MANAGEMENT IN HEALTHCARE TO SUPPORT GROWTH
• 8.6 REGULATORY & ACCREDITATION COMPLIANCE
  • 8.6.1 ENHANCING HEALTHCARE QUALITY THROUGH PROACTIVE REGULATORY AND ACCREDITATION COMPLIANCE MANAGEMENT TO DRIVE MARKET
• 8.7 PATIENT EXPERIENCE & ENGAGEMENT
  • 8.7.1 ENHANCING PATIENT EXPERIENCE AND ENGAGEMENT TO STRENGTHEN CARE QUALITY AND OPERATIONAL PERFORMANCE TO PROPEL MARKET

9 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HEALTHCARE PROVIDERS
  • 9.2.1 HOSPITALS
    • 9.2.1.1 Growing implementation of standardized care protocols and compliance measures to drive demand
  • 9.2.2 OUTPATIENT & AMBULATORY CARE CENTERS
    • 9.2.2.1 Growing need to streamline workflows and improve patient access to boost market
  • 9.2.3 PHYSICIAN & GROUP PRACTICES
    • 9.2.3.1 Ability to enhance care coordination and performance tracking to drive adoption
  • 9.2.4 LONG-TERM CARE & POST-ACUTE FACILITIES
    • 9.2.4.1 Benefits such as optimized patient safety and operational efficiency to fuel growth
  • 9.2.5 OTHER HEALTHCARE PROVIDERS
• 9.3 HEALTHCARE PAYERS
  • 9.3.1 PUBLIC PAYERS
    • 9.3.1.1 Leveraging data-driven insights to improve population health and ensure compliance to support growth
  • 9.3.2 PRIVATE PAYERS
    • 9.3.2.1 Ability of tools to track outcomes, identify care gaps, and optimize interventions to boost demand

10 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 US to dominate global market for healthcare quality management (QMS)
  • 10.2.3 CANADA
    • 10.2.3.1 Growing government support and digital health adoption to fuel market growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 UK
    • 10.3.2.1 Growing digital health infrastructure and clinical innovation to fuel market growth
  • 10.3.3 GERMANY
    • 10.3.3.1 Operational and regulatory challenges in Germany's healthcare quality management (QMS) market to limit growth
  • 10.3.4 FRANCE
    • 10.3.4.1 National quality strategies and hospital modernization to fuel market adoption
  • 10.3.5 ITALY
    • 10.3.5.1 Challenges and regional disparities in Italy's healthcare quality management (QMS) market to hinder growth
  • 10.3.6 SPAIN
    • 10.3.6.1 Value-based care reforms and digital reporting to drive Spain's healthcare quality management (QMS) market
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 JAPAN
    • 10.4.2.1 Integration of AI regulations to enhance healthcare quality management (QMS) in Japan
  • 10.4.3 CHINA
    • 10.4.3.1 Challenges and operational barriers in China's healthcare quality management (QMS) market to limit growth
  • 10.4.4 INDIA
    • 10.4.4.1 Public health reforms and regulatory oversight to drive growth in India's healthcare quality management (QMS) market
  • 10.4.5 SOUTH KOREA
    • 10.4.5.1 Digital transformation to drive healthcare quality management (QMS) market in South Korea
  • 10.4.6 AUSTRALIA
    • 10.4.6.1 Workforce shortages and varying levels of staff training to hinder market growth
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Brazil to dominate healthcare quality management (QMS) market in Latin America
  • 10.5.3 MEXICO
    • 10.5.3.1 Mexico to emerge as key healthcare quality management (QMS) market in Latin America
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Saudi Arabia
      • 10.6.2.1.1 Regulatory reforms and Vision 2030 investments to support market growth
    • 10.6.2.2 UAE
      • 10.6.2.2.1 Accreditation and patient safety initiatives to drive market growth
    • 10.6.2.3 Rest of Gcc Countries
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET
• 11.3 REVENUE ANALYSIS, 2020-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
• 11.5 BRAND/PRODUCT COMPARISON
• 11.6 COMPANY VALUATION & FINANCIAL METRICS
  • 11.6.1 FINANCIAL METRICS
  • 11.6.2 COMPANY VALUATION
• 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.7.1 STARS
  • 11.7.2 EMERGING LEADERS
  • 11.7.3 PERVASIVE PLAYERS
  • 11.7.4 PARTICIPANTS
  • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.7.5.1 Company footprint
    • 11.7.5.2 Region footprint
    • 11.7.5.3 Offering footprint
    • 11.7.5.4 Function footprint
    • 11.7.5.5 Use case footprint
    • 11.7.5.6 End-user footprint
• 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.8.1 PROGRESSIVE COMPANIES
  • 11.8.2 RESPONSIVE COMPANIES
  • 11.8.3 DYNAMIC COMPANIES
  • 11.8.4 STARTING BLOCKS
  • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 11.8.5.1 Detailed list of key startups/SMEs
    • 11.8.5.2 Competitive benchmarking of startups/SMEs
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES & ENHANCEMENTS
  • 11.9.2 DEALS
  • 11.9.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 NUANCE COMMUNICATIONS, INC. (MICROSOFT)
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products & services offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Right to win
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 PREMIER INC.
    • 12.1.2.1 Business overview
      • 12.1.2.1.1 Products & services offered
    • 12.1.2.2 Recent developments
      • 12.1.2.2.1 Product enhancements
      • 12.1.2.2.2 Deals
    • 12.1.2.3 MnM view
      • 12.1.2.3.1 Right to win
      • 12.1.2.3.2 Strategic choices
      • 12.1.2.3.3 Weaknesses & competitive threats
  • 12.1.3 OPTUM, INC. (UNITEDHEALTH GROUP)
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products & services offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches & enhancements
      • 12.1.3.3.2 Deals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Right to win
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses & competitive threats
  • 12.1.4 INTELEX TECHNOLOGIES (FORTIVE)
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products & services offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product launches & enhancements
      • 12.1.4.3.2 Expansions
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Right to win
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 DNV
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products & services offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches
      • 12.1.5.3.2 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Right to win
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses & competitive threats
  • 12.1.6 RLDATIX
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products & services offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product launches & enhancements
      • 12.1.6.3.2 Deals
      • 12.1.6.3.3 Other developments
    • 12.1.6.4 MnM view
      • 12.1.6.4.1 Right to win
      • 12.1.6.4.2 Strategic choices
      • 12.1.6.4.3 Weaknesses & competitive threats
  • 12.1.7 RISKONNECT, INC.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products & services offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product enhancements
      • 12.1.7.3.2 Deals
  • 12.1.8 HCI
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products & services offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product launches
      • 12.1.8.3.2 Other developments
  • 12.1.9 IDEAGEN
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products & services offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product launches
      • 12.1.9.3.2 Deals
  • 12.1.10 MEDISOLV, INC.
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products & services offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product approvals & enhancements
      • 12.1.10.3.2 Deals
  • 12.1.11 VALENZ HEALTH
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products & services offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Product launches
      • 12.1.11.3.2 Deals
  • 12.1.12 ODITEK SOLUTIONS
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products & services offered
  • 12.1.13 THE PATIENT SAFETY COMPANY (TPSC)
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products & services offered
    • 12.1.13.3 Recent developments
      • 12.1.13.3.1 Product enhancements
  • 12.1.14 MORCARE
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products & services offered
  • 12.1.15 YOUCOMPLY, LTD. (VICLARITY)
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products & services offered
    • 12.1.15.3 Recent developments
      • 12.1.15.3.1 Product launches & enhancements
  • 12.1.16 SIMPLERQMS
    • 12.1.16.1 Business overview
    • 12.1.16.2 Products & services offered
  • 12.1.17 NAVEX GLOBAL, INC. (GOLDMAN SACHS)
    • 12.1.17.1 Business overview
    • 12.1.17.2 Products & services offered
    • 12.1.17.3 Recent developments
      • 12.1.17.3.1 Product enhancements
      • 12.1.17.3.2 Deals
  • 12.1.18 PROVIDERTRUST
    • 12.1.18.1 Business overview
    • 12.1.18.2 Products & services offered
    • 12.1.18.3 Recent developments
      • 12.1.18.3.1 Product launches
      • 12.1.18.3.2 Deals
  • 12.1.19 MEDTRAINER
    • 12.1.19.1 Business overview
    • 12.1.19.2 Products & services offered
    • 12.1.19.3 Recent developments
      • 12.1.19.3.1 Product launches
      • 12.1.19.3.2 Deals
      • 12.1.19.3.3 Other developments
• 12.2 OTHER PLAYERS
  • 12.2.1 OKKALA SOLUTIONS PRIVATE LIMITED
  • 12.2.2 SAFEQUAL
  • 12.2.3 EFFIVITY TECHNOLOGIES, INC.
  • 12.2.4 TITLE21 HEALTH SOLUTIONS
  • 12.2.5 MEDBLAZE (INFINI)
  • 12.2.6 ETASKPRO
  • 12.2.7 QUALITYZE
  • 12.2.8 KARMINN CONSULTANCY NETWORK
  • 12.2.9 MEG

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS